| 1. | Plavix in high risk unstable angina : a report of 56 cases
氯吡格雷治疗高危不稳定型心绞痛56例 |
| 2. | International circulation ： how long is the time that the the patients should take plavix （ clopidogrel ） after intervention operation
问：您认为在介入手术后服用波力维（氯吡格雷）多长时间比较合适？ |
| 3. | It is well recognized that antiplatelet therapy is effective in the prevention and treatment of thrombosis
摘要抗血小板治疗可以有效预防和治疗血栓性疾病，氯吡格雷是一种新型安全高效的抗血小板药物。 |
| 4. | The pharmacology and the progress of synthesis research work of clopidogrel , an adp receptor antagonist , are briefly reviewed in this article
简要综述了氯吡格雷的药理学特性、与其他抗血小板药物的比较，以及国内外对其各种合成方法的研究进展。 |
| 5. | Background : anticoagulants and antiplatelet drugs ( e . g . , warfarin , clopidogrel and acetylsalicylic acid ) are key therapeutic agents in the treatment of cardiovascular diseases
背景：抗凝和抗血小板药物（如华法令、氯吡格雷、阿司匹林）是治疗心血管疾病的主要药物。 |
| 6. | A 71 - year - old man was admitted for coronary angiography because of arrhythmia and received clopidogrel ( dosage not stated ) , aspirin , verapamil and statins
1例71岁男性因心律不齐，接受氯吡格雷(剂量不详) 、阿斯匹林、异搏定和他汀类药物治疗，为进行冠状动脉造影术入院。 |
| 7. | Results of the ticlid or plavix post - stents （ topps ） trial : do they justify the switch from ticlopidine to clopidogrel after coronary stent placement
支架植入后抵克立得或氯吡格雷治疗疗效比较试验（ topps ）结果：它们足以构成冠脉支架植入后从抵克立得转为氯吡格雷治疗的理由吗？ |
| 8. | Zhangjiagang xinyu chemical is mainly engaged in producing pesticide intermediates . intermediates of dopidogrel . intermediates of atonrastatin , pesticide intermediate , series of carnitine and pharmaceutical intermediates
张家港市新宇化工厂主要生产医药中间体；氯吡格雷中间体，阿伐他汀钙中间体，肉碱系列和其它医药中间体。 |
| 9. | The researchers note that further studies are needed in patients not pretreated with antiplatelet agents , including those intolerant or allergic to aspirin or clopidogrel , and those with aspirin and / or clopidogrel resistance
研究者指出，还需进一步对未使用抗血小板药物的患者（包括不能耐受阿司匹林或氯吡格雷者、或对其过敏者，以及存在阿司匹林和/或氯吡格雷抵抗者）进行研究。 |
| 10. | Conclusions in patients 75 years of age or younger who have myocardiak infarction with st - segment ekevation and who receive aspirin and a standard fibrinokytic regimen ? the addition of ckopidogrek improves the patency rate of the infarct - rekated artery and reduces ischemic compkications
结论在年龄75岁、患有st段抬高心肌梗死并接受阿司匹林和标准纤溶方案治疗的病人中，加用氯吡格雷治疗可改善梗死相关动脉的通畅率，并减少缺血性并发症。 |
